期刊
LEUKEMIA
卷 31, 期 2, 页码 282-291出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/leu.2016.322
关键词
-
资金
- EU [692298]
- Associazione Italiana per la Ricerca sul Cancro AIRC, Milano, Italy [15189, 9965]
- Ricerca Finalizzata Ministero della Salute, Roma [2318823]
- Swedish Cancer Society
- Uppsala University Hospital
- Lion's Cancer Research Foundation, Uppsala
- Swedish Research Council
- Uppsala University
The discovery of almost identical or 'stereotyped' B-cell receptor immunoglobulins (BcR IG) among unrelated patients with chronic lymphocytic leukemia (CLL) cemented the idea of antigen selection in disease ontogeny and evolution. The systematic analysis of the stereotypy phenomenon in CLL revealed that around one-third of CLL patients may be grouped into subsets based on shared sequence motifs within the variable heavy complementarity determining region 3. Stereotyped subsets display a strikingly similar biology of the leukemic clones, referring to many different levels, from the immunogenetic and genetic and extending to the epigenetic and functional levels. Even more importantly, the homogeneity of stereotyped subsets has clinical consequences as patients assigned to the same stereotyped subset generally exhibit an overall similar disease course and outcome. In other words, stereotypy-based patient classification of CLL has already provided a more compartmentalized view of this otherwise heterogeneous disease and can assist in refining prognostication models. While this is relevant only for the one-third of cases expressing stereotyped BcR IG; in principle, however, the findings from further analysis of the stereotyped subsets may also contribute towards improved understanding of the remaining non-stereotyped fraction of CLL patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据